Determination of Tobramycin in M9 Medium by LC-MS/MS: Signal Enhancement by Trichloroacetic Acid

Liusheng Huang*, Janus Anders Juul Haagensen, Davide Verotta, Vincent Cheah, Alfred M. Spormann, Francesca Aweeka, Katherine Yang

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

399 Downloads (Pure)

Abstract

It is well known that ion-pairing reagents cause ion suppression in LC-MS/MS methods. Here, we report that trichloroacetic acid increases the MS signal of tobramycin. To support studies of an in vitro pharmacokinetic/pharmacodynamic simulator for bacterial biofilms, an LC-MS/MS method for determination of tobramycin in M9 media was developed. Aliquots of 25 μL M9 media samples were mixed with the internal standard (IS) tobramycin-d5 (5μg/mL, 25 μL) and 200 μL 2.5% trichloroacetic acid. The mixture (5 μL) was directly injected onto a PFP column (2.0 x 50 mm, 3 μm) eluted with water containing 20 mM ammonium formate and 0.14% trifluoroacetic acid and acetonitrile containing 0.1% trifluoroacetic acid in a gradient mode. ESI+ and MRM with ion m/z 468 → 324 for tobramycin and m/z 473 -> 327 for the IS were used for quantification. The calibration curve concentration range was 50-25000 ng/mL. Matrix effect from M9 media was not significant when compared with injection solvents, but signal enhancement by trichloroacetic acid was significant (∼ 3 fold). The method is simple, fast, and reliable. Using the method, the in vitro PK/PD model was tested with one bolus dose of tobramycin.
Original languageEnglish
Article number 7965124
JournalJournal of Analytical Methods in Chemistry
Volume2018
Number of pages8
ISSN2090-8865
DOIs
Publication statusPublished - 2018

Bibliographical note

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly cited.

Cite this